Camros Capital
4
20M
2
0.50
2
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Boston. The company was established in North America in United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2011. Comparing to the other companies, this Camros Capital performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2014.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Laser, Health Diagnostics. Among the various public portfolio startups of the fund, we may underline T2 Biosystems
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Camros Capital, startups are often financed by Flybridge Capital Partners, Polaris Partners, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are WS Investments, Polaris Partners, Physic Ventures. In the next rounds fund is usually obtained by WS Investments, Polaris Partners, Physic Ventures.
The fund was created by Parviz Tayebati. Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Health Diagnostics (3)
- National Security (1)
- Laser (1) Show 1 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| T2 Biosystems | 26 May 2010 | Biotechnology, Health Care, Health Diagnostics | Late Stage Venture | 15M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.